A NOTE FROM THE ICIS PRESIDENT, Christopher Hunter:

A NOTE FROM THE ICIS PRESIDENT, Christopher Hunter:

As we prepare for our annual scientific meeting in Hawaii, it is important to recognize the efforts of the organizing committee, chaired by James Turkson (Cedars Sinai Medical Center), to assemble a diverse scientific program with cutting edge research. For many of us, this will be our first in-person scientific meeting since the start of the COVID pandemic and will be an opportunity to reunite with international colleagues. The ability to hold this meeting in [READ MORE]

Society Business

  • At each Annual Scientific Meeting there shall be an Annual Business Meeting of the Membership of the Society, presided over by the President. Five percent of the Members shall constitute a quorum. This is the presentation of the 2021 Annual Business Meeting of the International Cytokine & Interferon Society which was postponed when the Annual meeting was not able to take place in Cardiff and pivoted to a Virtual Meeting. We invite members of the [READ MORE]

Cytokines 2022 Hybrid Joint Meeting with ILC4

Cytokines 2022 Hybrid Joint Meeting with ILC 4

Cytokines 2022 Hybrid: 10th Annual Meeting of the International Cytokine & Interferon Society (ICIS) to be held jointly with the 4th International Conference on Innate Lymphoid Cells (ILC4), September 20-23, 2022, at the Hilton Waikoloa Village, Big Island, Hawaii, USA, with synchronous Virtual Meeting Platform including live streamed and on-demand access to all sessions. Posters will be available both in-person (for those in Hawaii) AND as iPosters. [READ MORE]

New Member Mini-Bios

Rama K. Gurram, PhD

Rama K. Gurram, Ph.D.Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, USADr. Gurram received his Ph.D. in Immunology from the Jawaharlal Nehru University, New Delhi, India, under the [READ MORE]

Katherine A. Waugh, PhD

Katherine A. Waugh, Ph.D.Department of Pharmacology, University of Colorado – Anschutz Medical Campus, USADr. Waugh is an Instructor at the Linda Crnic Institute for Down Syndrome and the Department of Pharmacology on the University of [READ MORE]

Shehneela Baseer

Shehneela BaseerHannover Medical School, GermanyShehneela is doing her Ph.D. at Hannover Medical School, Germany. Her Ph.D. research focuses on the developing a deep understanding of the immune response in hepatitis B vaccinated non-responsive individuals using [READ MORE]

Erwin Le Scolan, PhD

Erwin Le ScolanCytomX Therapeutics, South San Francisco, USADr. Le Scolan has over 15 years of research experience in immuno-oncology. He joined CytomX in 2017 as a Scientist in Cancer Immunology. Dr. Le Scolan initiated and [READ MORE]

Venkat Giri Magupalli, PhD

Venkat Giri Magupalli Department of Pediatrics, Harvard Medical School, Boston, USA Venkat Giri Magupalli is an Assistant Professor at Harvard Medical School in the Department of Pediatrics. His research focuses on innate immune recognition of [READ MORE]

Other Meetings of Interest

Clinical Trials

Cytokine Clinical Trials

By Marta Catalfamo Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) ClinicalTrials.gov Identifier: NCT05080790  Contact: Daniel Pink, Dr.              033631 73527            daniel.pink@helios-gesundheit.de Contact: Melanie Prause              069 7601 4211          prause.melanie@ikf-khnw.de [READ MORE]

Special Article of Interest

Signals+ PDF

  • Signals+ Newsletter in PDF format for viewing, downloading and/or printing. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)

Stay connected & please share